Ifosfamide, cisplatin, vinblastine combination chemotherapy in the treatment of advanced non-small-cell lung cancer
Lung Cancer. 1991;7(4):272-273 
Mitomycin C, vinblastine and cisplatin combination chemotherapy in the treatment of advanced non-small cell lung cancer
Lung Cancer. 1989;5:36-37
Combination chemotherapy with bleomycin, etoposide, and cisplatin in metastatic non-small-cell lung cancer
Lung Cancer. 1986;2(3):228-229
Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer
Lung Cancer. 1995;12(3):303
Combination chemotherapy with cisplatin, ifosfamide and etoposide for small cell lung cancer
Lung Cancer. 1991;7:121
Superiority of three-drug combination chemotherapy vs cisplatin-etoposide in advanced non small cell lung cancer. A randomized trial of the Italian oncology group for clinical research
Lung Cancer. 1994;11:123
Cisplatin and etoposide (PE) vs cytoxan and etoposide (CE) in the chemotherapy (CT) of advanced non small cell lung cancer (NSCLC)
Lung Cancer. 1986;2(1-2):111
Phase I-II trial of cisplatin, vinblastine, and methylgluoxal-bis (guanylhydrazone) (MGBG) combination chemotherapy in non-small cell lung cancer
Lung Cancer. 1986;2(1-2):138
Effective symptom relief with moderate dose MVP (mitomycin-C, vinblastine, cisplatin) chemotherapy in advanced non-small cell lung cancer (NSCLC)
Lung Cancer. 1994;11:92
Cisplatin-vinorelbine combination chemotherapy in locally advanced non-small cell lung cancer
Lung Cancer. 1996;16(1):124